CClinicalTrials.gg
CompletedNCT02516891Updated Apr 6, 2016

Jailed Wire Technique in the Treatment of Coronary Bifurcations Lesions With Stent: Stereoscopic Microscopy Study

A Phase 4 interventional study of Drug-Eluting Stents implantation in bifurcation lesions in Coronary Health Disease, sponsored by Maimónides Biomedical Research Institute of Córdoba. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2016-04-06.

Sponsored by Maimónides Biomedical Research Institute of Córdoba · Phase 4, Interventional, and Health services research

Phase
Phase 4
Study type
Interventional
Enrollment
235
Allocation
Randomized
Sex
All
01

Study summary

The aims of this study are: 1) To identify more resistant the guidewire type to the retrieval maneuvers after the jailing.

  1. To determined anatomic and technical factors influencing the induced damage in the guidewire.

Design of the study: prospective randomized study to compare 2 types of guidewire: hydrophilic and no hydrophilic. Patients and methods: Two hundred patients with bifurcation coronary lesions will be included. All of then will be treated by provisional side-branch stenting using the jailed wire technique. One hundred patients will be randomized to hydrophilic wires and another 100 patients to non-hydrophilic wires.

Read the detailed description

The percutaneous approach of bifurcation lesions is a complex procedure; when the stent is implanted at main vessel, a closure of the side-branch may occur. The re-wiring of the side-branch in these conditions may be difficult or even impossible. To facilitate the re-wiring maneuvers the operators use the jailed wired technique. For this technique a guide-wire is introduced in the side-branch before main vessel stent implantation; after the stent deployment the wire remains jailed between the vessel wall and the metallic structure of the stent. If the side-branch became occluded, this wire is a good landmark of it is position, facilitating the access with a new wire. However, the rupture of the wire has been described in some cases, during the retrieval maneuvers.

02

Conditions studied

  • Coronary Health Disease

Keywords

  • treatment
  • stent
  • coronary bifurcations lesions
03

In context

Lead sponsor

Maimónides Biomedical Research Institute of Córdoba is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with atherosclerotic coronary disease and bifurcation lesions requiring protection with side branch.
  • The art of imprisoned guide.
  • The main branch should be greater than 2.5 mm in diameter at the operator's visual estimate.
  • The side branch must exceed 2 mm in diameter or have sufficient authority to protect the operator decides with a guide for the release of the main vessel stent.
  • Patients with the above characteristics and main or side branch of any length.
  • Patients with bifurcation lesions with any morphology of the Medina classification: 1 1 1 1 0 1 0 1 1, 110, 001, 010, 100.
  • Treatment of bifurcation with any technique and any type of stent in the side branch meets the criteria above.
  • Symptoms of stable angina or acute coronary syndrome.

Exclusion criteria

Exclusion Criteria:

  • Patients with collateral bouquet of little significance.
  • Patients in cardiogenic shock.
  • Patients in whom it is impossible to guide the placement of the side branch before implantation in the glass principal.
  • Patients who do not give their consent for the study.
05

Study design

Phase
Phase 4
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
235 participants (actual)

Study arms

  • Experimental
    hydrophilic wire/Drug-Eluting Stents

    Will include 100 patients with coronary bifurcation lesions in that they will be treated with stents and in which the technique is used jailed guide.

    Device: Drug-Eluting Stents implantation in bifurcation lesions

  • No intervention
    Non hydrophilic wire/Drug-Eluting Stents

    Will include 100 patients with coronary bifurcation lesions in that they will be treated with stents and in which the technique is used jailed guide.non hydrophilic guide.

Interventions

  • DeviceDrug-Eluting Stents implantation in bifurcation lesions
06

What researchers measure

Primary outcomes

  1. No damage: the guidewire suffered no loss of integrity over its entire length

    Time frame: 3 years

  2. Slight damage: the external cover suffered loss of integrity < 2 mm

    Time frame: 3 years

  3. Moderate damage: the external cover suffered loss of integrity > 2 mm

    Time frame: 3 years

  4. Severe damage: visible changes to the inner cover of the guidewire.

    Time frame: 3 years

  5. Fracture: discontinuity at some point along the guidewire

    Time frame: 3 years

07

Study locations

1 site
  • Hospital Universitario Reina Sofía
    Córdoba, 14004, Spain
08

References and documents

Publications

  • Pan M, Ojeda S, Villanueva E, Chavarria J, Romero M, Suarez de Lezo J, Mazuelos F, Segura J, Carrasco F, Hidalgo F, Lopez Aguilera J, Rodriguez S, Puente M, Suarez de Lezo J. Structural Damage of Jailed Guidewire During the Treatment of Coronary Bifurcation Lesions: A Microscopic Randomized Trial. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1917-24. doi: 10.1016/j.jcin.2016.06.030. PubMed 27659568 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02516891
Lead sponsor
Maimónides Biomedical Research Institute of Córdoba
Collaborators
Instituto de Salud Carlos III
Responsible party
Sponsor
First posted
Aug 6, 2015
Start date
Feb 2012
Primary completion
Jun 2015
Completion
Feb 2016
Last update
Apr 6, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion